Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Date of authorisation: 19/06/2026, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 July 2026 - 16:30

Human medicines European public assessment report (EPAR): Rexatilux, ranibizumab, Date of authorisation: 19/06/2026, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rexatilux

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters